Skip to product information
1 of 4

Alfasigma S.p.A.

Alfasigma L-Carn levocarnitine Drinking Solution 30 × 10 ml Pack

Alfasigma L-Carn levocarnitine Drinking Solution 30 × 10 ml Pack

Regular price £293.16 GBP
Regular price £318.54 GBP Sale price £293.16 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.

Alfasigma L-Carn levocarnitine Drinking Solution  30 × 10 ml Pack

Availability :
Available in 5-7 working days slower.

L‑Carn Trinklösung delivers 1 g of levocarnitine per 10 ml of clear aqueous solution. It is intended for substitution therapy in primary or secondary systemic carnitine deficiency. The formulation contains 48 mg of sodium benzoate as a preservative. Recommended intake is one ampoule three times daily, taken undiluted or with water or tea. The solution supports fatty‑acid metabolism and may improve muscle strength in patients with carnitine‑related disorders. Store the bottle protected from heat and keep out of reach of children.

Active Ingredient: Levocarnitin
Concentration: 1 g per 10 ml
Package Size: 30 × 10 ml
Formulation: Oral solution
Preservative: 48 mg Sodium Benzoate
Indications: Carnitine deficiency therapy
Storage Conditions: Protect from heat, store below 25 °C
Shelf Life: 24 months

Important information (mandatory information):

L-Carn oral solution.
 Active ingredient: 1 g levocarnitine/10 ml solution. Indications: Used for the treatment of carnitine deficiency disorders (levocarnitine replacement therapy):

 To compensate for levocarnitine losses due to defects of the so-called carnitine transporter in the cell membrane (replacement in primary systemic carnitine deficiency).

 To compensate for levocarnitine losses that can be caused by various diseases and as side effects of certain treatments (replacement in secondary systemic carnitine deficiency). To compensate for treatment-related levocarnitine losses that can occur as a result of long-term hemodialysis in patients with kidney failure (replacement of dialysis-related levocarnitine losses in chronic hemodialysis, i.e., as a consequence of secondary levocarnitine deficiency).

As a treatment option for specific forms of muscular dystrophy with accompanying fatty degeneration of the muscles, caused by a levocarnitine deficiency (muscular dystrophy with lipid accumulation based on a primary muscular levocarnitine deficiency).
Contains 48 mg sodium benzoate.

Source: Package insert information,
as of 09/2025

Alfasigma L-Carn levocarnitine Drinking Solution  30 × 10 ml Pack

Materials

Shipping & Returns

Dimensions

Care Instructions

View full details